1997
DOI: 10.1086/516545
|View full text |Cite
|
Sign up to set email alerts
|

DNA Vaccination with the Major Outer‐Membrane Protein Gene Induces Acquired Immunity toChlamydia trachomatis(Mouse Pneumonitis) Infection

Abstract: The efficacy of DNA vaccination for prevention of Chlamydia trachomatis infection was studied using the murine model of pneumonia induced by the mouse pneumonitis (MoPn) isolate of C. trachomatis. Intramuscular DNA immunization with two chlamydial genes, one that encodes the major outer-membrane protein (MOMP) and one that encodes a cytoplasmic enzyme (cytosine triphosphate [CTP] synthetase) were tested. The MOMP DNA vaccine but not the CTP synthetase DNA vaccine generated significant delayed-type hypersensiti… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

8
65
1
1

Year Published

1999
1999
2016
2016

Publication Types

Select...
5
4
1

Relationship

1
9

Authors

Journals

citations
Cited by 103 publications
(75 citation statements)
references
References 23 publications
8
65
1
1
Order By: Relevance
“…We have demonstrated in previous studies that DNA vaccination using the chlamydial MOMP gene (omp1) induces both IL-12 and IL-10 production but provides significant protection (50). Moreover, we have also shown that vaccination with live, compared with dead, chlamydial organisms induced both higher IL-12 as well as IL-10 but provided strong protection (41).…”
Section: Discussionmentioning
confidence: 96%
“…We have demonstrated in previous studies that DNA vaccination using the chlamydial MOMP gene (omp1) induces both IL-12 and IL-10 production but provides significant protection (50). Moreover, we have also shown that vaccination with live, compared with dead, chlamydial organisms induced both higher IL-12 as well as IL-10 but provided strong protection (41).…”
Section: Discussionmentioning
confidence: 96%
“…Recombinant MOMP, MOMP synthetic peptides, DNA vaccines encoding MOMP, and the passive transfer of MOMP-specific monoclonal antibodies have been evaluated for protective efficacy. All studies have yielded disappointing results since protective immunity either was not generated or was partial, at best (18,25,32,36,67,70,71,79,102,120,121). The reason for the ineffectiveness of MOMP as a vaccine is not known, but it may result from adjuvants or delivery systems that ineffectively target genital tract mucosae or from use of MOMP immunogens that do not mimic the native structure of the protein (69).…”
Section: Vaccine Prospectives and Challengesmentioning
confidence: 99%
“…DNA vaccination has already been used to elicit protective immune responses against Chlamydia trachomatis, Chlamydophila pneumoniae and Chlamydophila psittaci [10,15,16]. In preliminary studies, a DNA vaccine encoding the heat shock protein (hsp) DnaK (also called Hsp70) of Chlamydophila abortus induced a humoral response with an IgG2a predominant isotype [8].…”
Section: Introductionmentioning
confidence: 99%